KNOW Bio – REVIAN® Presents Leading Clinical Trial Results for New Hair Loss Treatment
Industry-leading 26.3 more hairs/cm2 on average after 16 weeks of 10-minutes a day LED light therapy
Significant reductions in itching and burning of the scalp also reported
Durham, N.C. – January 21, 2020 – REVIAN Inc. (formerly PhotonMD Inc.) – a medical technology company dedicated to stimulating the body’s natural processes to rejuvenate hair and skin with light – is excited to announce that final data from a randomized, double-blind study of the REVIAN RED hair growth system was presented at the 2020 Winter Clinical Dermatology Conference – Hawaii®. The data is now available on the REVIAN website following presentation at the conference. In this clinical trial, REVIAN RED successfully demonstrated the ability to stop hair loss and subsequently grow new hair.